These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21888239)

  • 1. Cytogenetic evaluation of Fansidar on human lymphocyte chromosomes in vitro.
    Praveen N; Saifi MA; Shadab GG
    J Environ Biol; 2011 Jan; 32(1):95-8. PubMed ID: 21888239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes.
    Abou-Eisha A; Afifi M
    Cell Biol Toxicol; 2004 Sep; 20(5):303-11. PubMed ID: 15685933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance.
    Wang P; Sims PF; Hyde JE
    Parasitology; 1997 Sep; 115 ( Pt 3)():223-30. PubMed ID: 9300459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clastogenic effect of pyrimethamine (Daraprim) on human chromosomes in lymphocyte cultures.
    Egeli U; Erdogan G
    Cell Biol Toxicol; 1991 Oct; 7(4):347-56. PubMed ID: 1794109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophage induction by 4 antimalaria drugs (daraprim, fansidar, nivaquine and camoquine) and in combination with aflatoxin B1.
    Fasunon OD; Uwaifo AO
    Mutat Res; 1989 Apr; 222(4):311-6. PubMed ID: 2495438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine.
    Shao BR; Huang ZS; Shi XH; Zhan CQ; Meng F; Ye XY; Huang J; Ha SH
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):257-63. PubMed ID: 2692191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
    Ittiravivongs A; Vasuvat C; Kongrod S
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):323-5. PubMed ID: 6395351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The modelling of the multiple drug resistance of the malarial parasites. 1. The combined resistance of Plasmodium berghei to chloroquine and fansidar].
    Khanmirzoev FI; Kulikovskaia IM; Dadasheva NR; Rabinovich SA
    Med Parazitol (Mosk); 1990; (5):60-3. PubMed ID: 2266909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute hepatitis following administration of fansidar].
    Meier P; Schmid M; Stäubli M
    Schweiz Med Wochenschr; 1990 Feb; 120(7):221-5. PubMed ID: 2309111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy study of combination fansidar-sulphate quinine and fansidar-HCl tetracycline in falciparum malaria in children above 7 years old.
    Silitonga K; Rampengan TH
    Paediatr Indones; 1991; 31(3-4):111-6. PubMed ID: 1956689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of fragile sites induced by pyrimethamine.
    Egeli U; Tunca B
    Teratog Carcinog Mutagen; 1997; 17(2):59-69. PubMed ID: 9261920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of amodiaquine, Fansidar and their combination in the treatment of chloroquine-resistant falciparum malaria].
    Huang QL; Quyang WC; Zhou JX; Wu Z; Zhang KY; Huang JK; Pan XJ; Cai XZ; Fu SG; Huang XF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(4):292-5. PubMed ID: 3075526
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
    Deacon HE; Freese JA; Sharp BL
    S Afr Med J; 1994 Jul; 84(7):394-5. PubMed ID: 7709301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Aristolochia petersiana on the efficacy of fansidar.
    Kazembe T; Munyarari E
    Cent Afr J Med; 2006; 52(1-2):11-6. PubMed ID: 17892234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.